Disse patienter bør have voriconazol oralt, medmindre fordelen ved administration af intravenøst voriconazol opvejer den potentielle risiko.
Oral voriconazole should be administered to these patients, unless an assessment of the risk benefit to the patient justifies the use of intravenous voriconazole.